Absolute miserable trade.... I remember this stock being choppy after the RCT entry earlier this week, so decided to give it some extra room when I entered the trade today based on its phase two cancer study. It was choppy right away and was struggling to spike more, however, I held it and it started dipping. I ended up taking a $44 loss, which is unacceptable. Brutal trade but good lesson.